Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 679-687

  Benítez, María Belén ^a   Cuniberti, Luis ^b   Fornari, María Cecilia ^c   Gómez Rosso, Leonardo ^a   Berardi, Vanina ^c   Elikir, Gerardo ^b   Stutzbach, Pablo ^b   Schreier, Laura ^a   Wikinski, Regina ^a   Brites, Fernando ^a,d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b FAVALORO UNIVERSITY   (Argentina)

^c Bioalpha Laboratory   (Argentina)

^d Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Adhesion molecules; Atherosclerosis; Hypertriglyceridemia; Leukocytes

Indexed keywords

CD18 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CHEMICAL COMPOSITION; CONTROLLED STUDY; FUNCTIONAL DISEASE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK ASSESSMENT;

ADULT; ANTIGENS, CD18; CASE-CONTROL STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; INTERCELLULAR ADHESION MOLECULE-1; MALE; METABOLIC SYNDROME X; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 40949159203     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.04.005     Document Type: Article

References (46)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Huo Y., and Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 173 (2001) 35-43
3. Saku K., Zhang B., Ohta T., et al. Levels of soluble cell adhesion molecules in patients with angiographically defined coronary atherosclerosis. Jpn Circ J 63 (1999) 19-24
4. Tian J., Pei H., James J.C., et al. Circulating adhesion molecules in apoE-deficient mouse strains with different atherosclerosis susceptibility. Biochem Biophys Res Commun 329 (2005) 1102-1107
5. Kaikita K., Ogawa H., Yasue H., et al. Increased plasma soluble intercellular adhesion moleclule-1 levels in patients with acute myocardial infarction. Jpn Circ J 61 (1997) 741-748
6. Hwang S.J., Ballantyne C.M., Sharrett A.R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 (1997) 4219-4225
7. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
8. Lundman P., Eriksson M., Stuhlinger M., et al. Mild to moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentration of asymmetric dimethylarginine. J Am Coll Cardiol 38 (2001) 111-116
9. de Man F.H., Weverling-Rijnsburger A.W., van der Laarse A., et al. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. Arterioscler Thromb Vasc Biol 20 (2000) 744-750
10. Brites F., Bonavita C., Cloës M., et al. VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein. Clin Chim Acta 269 (1998) 107-124
11. Brites F., Bonavita C., De Geitere C., et al. Alterations in the main steps of reverse colesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis 152 (2000) 181-192
12. Brites F., Verona J., Schreier L., et al. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low HDL-cholesterol levels with or without primary hypertrigliceridemia. Arch Med Res 35 (2004) 235-240
13. Austin M.A., Hokanson J.E., and Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81 (1998) 7B-12B
14. Assmann G., Schulte H., Funke H., and von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J 19 (1998) M8-M14
15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
16. Assmann G., Jabs H.U., Kohnert U., Nolte W., and Schriewer H. LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with polyvinilsulfate. Clin Chim Acta 140 (1984) 77-83
17. Warnick G.R., Benderson J., and Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
18. Bartlett G.R. Phosphorus assay in column chromatography. J Biol Chem 234 (1959) 466-468
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Schumaker V.N., and Puppione D.L. Sequential flotation ultracentrifugation. Methods Enzymol 128 (1986) 155-170
21. Lagrost L., Gandjini H., Athias A., et al. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 13 (1993) 815-825
22. Blank M.L., Hall M.N., Cress A.E., and Snyder F. Inactivation of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by a plasma acetylhydrolase: higher activities in hypertensive rats. Biochem Biophys Res Commun 113 (1983) 666-671
23. Furlong C.E., Richter R.J., Seidel S.L., Costa L.G., and Motulsky A.G. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of clorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 180 (1989) 242-247
24. Fornari M.C., Sarto A., Berardi V., et al. Effect of ovaric hyper-stimulation on blood lymphocyte subpopulations, cytokines, leptin and nitrite among patients with unexplained infertility. Am J Reprod Immunol 48 (2002) 394-403
25. Lundman P., Eriksson M.J., Silveira A., et al. Relation of hypertriglyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-reactive Protein, Interleukin-6, soluble adhesion molecules, von Willebrand factor, and Endothelin-1). Am J Cardiol 91 (2003) 1128-1131
26. Hackman A., Abe Y., Insull Jr. W., et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 93 (1996) 1334-1338
27. Abe Y., El-Masri B., Kimball K.T., et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 18 (1998) 723-731
28. Lupattelli G., Lombardini R., Schillaci G., et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 140 (2000) 521-526
29. Matsumoto K., Miyake S., Yano M., Ueki Y., and Tominaga Y. High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia. Atherosclerosis 152 (2000) 415-420
30. Cominacini L., Fratta Pasini A., Garbin U., et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38 (1995) 1122-1124
31. Matsumoto K., Sera Y., Nakamura H., Ueki Y., and Miyake S. Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 55 (2002) 131-138
32. Musial K., Zwolinska D., Polak-Jonkisz D., et al. Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol 20 (2005) 52-55
33. Papayianni A., Alexopoulos E., Giamalis P., et al. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant 17 (2002) 435-441
34. Kawakami A., Tanaka A., Nakajima K., Shimokado K., and Yoshida M. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 91 (2002) 263-271
35. Wanten G.J., Geijtenbeek T.B., Raymakers R.A., et al. Medium-chain, triglyceride-containing lipid emulsions increase human neutrophil beta 2 integrin expression, adhesion, and degranulation. J Parenter Enteral Nutr 24 (2000) 228-233
36. Van Oostrom A.J., van Wijk J.P., Sijmonsma T.P., Rabelink T.J., and Castro Cabezas M. Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. Neth J Med 62 (2004) 320-325
37. Sampson M.J., Davies I.R., Brown J.C., Ivory K., and Hughes D.A. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22 (2002) 1187-1193
38. Caimi G., Montana M., Ferrara F., et al. Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetes subjects with macrovascular complications. Acta Diabetol 40 (2003) 14-19
39. Grykiel K., Zozulinska D., Kostrzewa A., Wiktorowicz K., and Wierusz-Wysocka B. Evaluation of expression of polymorphonuclear neutrophil surface receptors in patients with type 1 diabetes. Pol Arch Med Wewn 105 (2001) 377-381
40. Song H., Wang L., and Hui Y. Expression of CD18 on the neutrophils of patients with diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 245 (2007) 24-31
41. Dunbar R.L., and Rader D. Demystifying triglycerides: a practical approach for the clinician. Cleve Clin J Med 72 (2005) 661-680
42. Hersberger M., and von Eckardstein A. Low high-density lipoprotein cholesterol. Physiological background, clinical importance and drug treatment. Drugs 63 (2003) 1907-1945
43. Cockerill G.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15 (1995) 1987-1994
44. Calabresi L., Franceschini G., Sirtori C.R., et al. Inhibition of VCAM-1 expression in endhotelial cells by reconstituted high density lipoprotein. Biochem Biophys Res Commun 238 (1997) 61-65
45. Xia P., Vadas M.A., Rye K.A., Barter P.J., and Gamble J.R. High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL. J Biol Chem 274 (1999) 33143-33147
46. Ahmed W., Orasanu G., Nehra V., et al. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 98 (2006) 490-498